Active Clinical Trials at OOS

All Clinical Trials

BDX-00146 (BIODESIX)

Tumor site:
Lung
Description:
An Observational Study Assessing the Clinical Effectiveness of the VeriStrat® Test and Validating Immunotherapy Tests in Subjects with Non-Small Cell Lung Cancer (INSIGHT)
Available at:

Bespoke 20-041-NCP (BESPOKE)

Tumor site:
Colorectal
Description:
An Observational Study of ctDNA Guided Therapy in Colorectal Cancer.
Available at:

Bespoke IO 20-043-NCP (BESPOKE)

Tumor site:
Lung, Melanoma, Colorectal
Description:
A BESPOKE Study of ctDNA Guided Immunotherapy for Non-Small cell lung cancer, Melanoma, and Colorectal cancer.
Available at:

CORFU (AstraZeneca)

Tumor site:
Lung: NSCLC
Description:
Retrospective/Observational Study of Risk of Adverse Events in NSCLC Patients Treated with Immune Checkpoint Inhibitors Followed by EGFR Tyrosine Kinase Inhibitors
Available at:

I3Y-MC-JPCW(b) (Eli Lilly)

Tumor site:
Breast
Description:
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib plus Standard Adjuvant Endocrine Therapy in Participants with High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy NCT number: NCT04752332
Available at:

LOXO-BTK-20019 (J2N-OX-JZNM)

Tumor site:
Mantle Cell Lymphoma
Description:
A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
Available at:

Mirati KRYSTAL 7 (Mirati 849-007)

Tumor site:
Lung (NSCLC)
Description:
Phase 2 Trial of MRTX849 Plus Pembrolizumab for NSCLC With KRAS G12C Mutation (KRYSTAL-7)
Available at:
Notes:
NCT: 04613596

Prevalence (64091742PCR0002)

Tumor site:
Prostate
Description:
Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer. Observational study.
Available at:

Mirati KRYSTAL 12 (Mirati 849-012)

Tumor site:
Lung (NSCLC)
Description:
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)
Available at:
Notes:
NCT: 04685135
Page 1 of
Page: